Stockreport

Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating [Seeking Alpha]

MEI Pharma, Inc.  (MEIP) 
Last mei pharma, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.meipharma.com
PDF The company's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Kyowa Kirin is well-capitalized with [Read more]